NRSN vs NEUP
Comparison between NeuroSense Therapeutics Ltd (NRSN, Company) and Neuphoria Therapeutics Inc (NEUP, Company).
Both NRSN and NEUP are from the Healthcare sector.
NRSN vs NEUP - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
Winner
NRSN
$24M
NEUP
$24M
Max Drawdown
Winner
NRSN
92.90%
NEUP
96.32%
Sharpe Ratio
NRSN
-0.92
Winner
NEUP
0.35
5Y Beta
Winner
NRSN
0.62
NEUP
1.34
Industry
NRSN
Biotechnology
NEUP
Biotechnology
P/E Ratio
Winner
NRSN
-2.14
NEUP
-1.06
5Y EPS CAGR
NRSN
-17.43%
NEUP
N/A
Debt to Equity
NRSN
0.00%
NEUP
0.00%
Free Cash Flow Yield
Winner
NRSN
-32.25%
NEUP
-72.16%
P/S Ratio
NRSN
N/A
NEUP
1.70
P/B Ratio
NRSN
2.64
Winner
NEUP
0.81
NRSN vs NEUP - Historical Returns
Returns include dividend reinvestment.
1M
NRSN
-15.44%
Winner
NEUP
-9.51%
3M
NRSN
-13.83%
Winner
NEUP
-6.75%
6M
NRSN
-17.76%
Winner
NEUP
+9.74%
1Y
NRSN
-71.47%
Winner
NEUP
-36.12%
5Y(CAGR)
NRSN
-32.18%
NEUP
N/A
Max(CAGR)
Winner
NRSN
-32.18%
NEUP
-76.51%
NRSN vs NEUP - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | NRSN | NEUP |
|---|---|---|
| 2026 | -10.37% | +12.04% |
| 2025 | -33.13% | +32.42% |
| 2024 | +50.00% | -90.59% |
| 2023 | -42.28% | N/A |
| 2022 | -54.31% | N/A |
| 2021 | -39.11% | N/A |
NRSN vs NEUP Drawdown Comparison
The maximum drawdown for NRSN was -92.90%, occurring on Oct 30, 2023. This drawdown has not yet recovered.
The maximum drawdown for NEUP was -96.32%, occurring on Jan 2, 2025. This drawdown has not yet recovered.
The current NRSN drawdown is -88.78%. The current NEUP drawdown is -94.62%.
| Rank | NRSN | NEUP |
|---|---|---|
| #1 | -92.90% Mar 21, 2022 - Oct 30, 2023 | -96.32% Dec 24, 2024 - Jan 2, 2025 |
| #2 | -67.08% Dec 9, 2021 - Mar 21, 2022 | N/A |
Correlation
Correlation between NRSN and NEUP is 0.44 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
0.44
-101
Select Stocks to Compare
Popular: NRSN vs SPYNEUP vs SPY
More Comparisons
Compare with similar stocks